Max Healthcare Institute Limited (NSE:MAXHEALTH)
India
· Delayed Price · Currency is INR | Market Cap | 981.77B |
| Revenue (ttm) | 65.42B |
| Net Income (ttm) | 10.08B |
| Shares Out | n/a |
| EPS (ttm) | 10.31 |
| PE Ratio | 97.36 |
| Forward PE | n/a |
| Dividend | 1.50 (0.15%) |
| Ex-Dividend Date | n/a |
| Volume | 926,519 |
| Average Volume | 2,792,486 |
| Open | 1,031.90 |
| Previous Close | 1,031.85 |
| Day's Range | 1,005.00 - 1,039.10 |
| 52-Week Range | 706.45 - 1,227.95 |
| Beta | 0.28 |
| RSI | 41.32 |
| Earnings Date | Jan 30, 2025 |
About Max Healthcare Institute
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to pa... [Read more]
Financial Performance
In 2023, Max Healthcare Institute's revenue was 54.06 billion, an increase of 18.49% compared to the previous year's 45.63 billion. Earnings were 10.58 billion, a decrease of -4.16%.
Financial StatementsNews
Max Healthcare shares surge 2% as UBS upgrades to ‘Buy’ rating with target price of Rs 1,200
Max Healthcare shares jumped 2% after UBS upgraded the stock to ‘Buy’ from ‘Neutral’ and raised its target price to ₹1,200. As of 9:39 AM, the shares were trading 1.63% higher at Rs 1,031.20. The brok...
UBS upgrades Max Healthcare to ‘Buy’, raises target to ₹1,200 on strong expansion visibility
UBS has upgraded Max Healthcare to Buy from Neutral and raised its target price to ₹1,200, citing strong visibility on bed additions and faster break-even of new hospitals. The brokerage believes the ...
Q3 2025 Max Healthcare Institute Ltd Earnings Call Transcript
Q3 2025 Max Healthcare Institute Ltd Earnings Call Transcript
Max Healthcare shares in focus: HSBC maintains Hold, sees limited downside post Q3 operational beat
Max Healthcare shares are in focus following a solid Q3FY25 performance, though HSBC has maintained a Hold rating, signaling cautious optimism despite operational improvements. The stock is currently ...
Max Healthcare Q3 FY25 Results: Revenue surges 40% YoY to Rs 1,868 crore, Net Profit down 17.6% YoY
Max Healthcare Institute Limited reported strong Q3 FY25 financial results, showcasing significant growth in revenue and profitability. The company’s revenue from operations increased to Rs 1,868 cror...
Top Q3 FY25 Results Today on January 30, 2025: Adani Enterprises, Adani Ports, Bajaj Finserv, BEL, Biocon, Dabur, Prestige Estates
A host of prominent companies, including Adani Enterprises, Adani Ports, Astral, Bajaj Finserv, Bank of Baroda, BEL, Biocon, Coromandel International, Dabur, Max Healthcare, Navin Fluorine, and Presti...
Stock Market Update, January 8: Anant Raj, PTC Industries, Max Healthcare, Apar Industries and more hit 52-week highs today
The Indian equity markets faced a day of high volatility on January 8, with the BSE Sensex and Nifty 50 indices ending in the red. The BSE Sensex experienced a minor decline of 50.62 points (0.06%), s...
Stock Market Update: Muthoot Finance, Infosys, Max Healthcare and more hit 52-week highs today on December 12, 2024
Indian equity markets faced a challenging trading day on December 12, 2024, with both the Sensex and Nifty indices closing in the red. The Sensex slipped by 236.18 points, or 0.29%, ending the session...
Max Healthcare shares jumpe nearly 3% after Axis Capital initiates “Buy” rating
Max Healthcare shares surged nearly 3% after Axis Capital initiated coverage with a BUY rating and a target price of Rs 1,315. As per Axis Capital, Max Healthcare operates over 2,900 beds and dominate...
Max Healthcare Institute: Stock closes 16.69% below 52-week high, 70.50% above 52-week low
Max Healthcare Institute (NSE: MAXHEALTH) ended trading on November 17, 2024, at ₹1,006.25, reflecting a slight gain of 0.43%. The stock remains 16.69% below its 52-week high of ₹1,207.50 and 70.50% a...
Max Healthcare shares surge 2% after acquisition of Jaypee Healthcare for Rs 227 crore
Max Healthcare’s stock rose 2% in morning trade following the completion of its acquisition of Jaypee Healthcare Limited (JHL). On November 11, 2024, Max Healthcare finalized the purchase of JHL’s rem...
Max Healthcare completes 100% acquisition of Jaypee Healthcare for Rs 227 crore
In a significant development, Max Healthcare has announced the completion of its acquisition of Jaypee Healthcare Limited (JHL), achieving full ownership of the healthcare entity. This acquisition, wh...
Max Healthcare shares rise nearly 3%, emerge as top gainer in morning trade
Max Healthcare Institute shares rise nearly 3%, emerging as one of the top gainers this morning. The stock opened at ₹1,028 and reached an intraday high of ₹1,049.80 on the NSE, showing a 2.47% increa...
Major Block Trades Today: Mahindra & Mahindra ₹168.49 crore, PB Fintech ₹150.85 crore, Max Healthcare ₹95.05 crore
Several large block trades took place on the NSE today, involving major companies like Mahindra & Mahindra, Max Healthcare Institute, and PB Fintech. Here are the key details: Max Healthcare Institute...
Jaypee Infratech sells 63.65% stake in Jaypee Healthcare to Max Healthcare for ₹398 crore
Jaypee Infratech Limited has sold 63.65% of its equity stake in Jaypee Healthcare Limited (JHL) to Max Healthcare Institute Limited for a total amount of ₹398 crore. The sale was part of a proposal su...
Max Healthcare set to take over Jaypee hospitals
Max Healthcare plans to acquire a 64% stake in Jaypee Healthcare for Rs 1,660 crore, which includes the flagship 500-bed Jaypee Hospital in Noida. This strategic move aims to bolster medical infrastru...
Max Healthcare collaborates with Lakshdeep Group for turnaround and acquisition of controlling stake in Jaypee Healthcare
Max Healthcare Institute Ltd has recently informed exchanges that the company has signed a strategic collaboration agreement with Lakshdeep Group, the ultimate promoter group of Jaypee Healthcare Limi...
Max Healthcare shares surge 4% for second day in a row
Shares of Max Healthcare Institute jumped more than 4% in the morning trade for the second day in a row. In the exchange filing on Wednesday, the company shared, “The Board of Directors of ET Planners...